• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“摘樱桃”法,一种多部位非解剖性肝切除技术,是神经内分泌肿瘤患者弥漫性肝转移的一种有前景的选择。

"Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.

作者信息

Krausch Markus, Raffel Andreas, Anlauf Martin, Schott Matthias, Lehwald Nadja, Krieg Andreas, Topp Stefan Andreas, Cupisti Kenko, Knoefel Wolfram Trudo

机构信息

Department of General, Visceral and Pediatric Surgery, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225, Duesseldorf, Germany,

出版信息

World J Surg. 2014 Feb;38(2):392-401. doi: 10.1007/s00268-013-2267-3.

DOI:10.1007/s00268-013-2267-3
PMID:24101025
Abstract

INTRODUCTION

Liver metastases of GEP-NETs are a known major prognostic factor with a strong effect on patients' survival. To date, various treatment options are available, whereas surgery remains the only curative option. Because large liver resections often cannot be performed due to insufficient remnant liver volume, a special operative technique, "cherry picking" (multiple nonanatomic liver resections), can be used as a tissue-preserving procedure.

METHODS

Of 91 patients with various GEP-NETs, 16 patients were identified with synchronous or metachronous multifocal, bilobular liver metastases (>10). All were treated with "cherry picking." Patient records were reviewed retrospectively and clinical data and pathology results were analyzed.

RESULTS

Mean survival after primary tumour resection was 82.8 versus 41.2 months after liver surgery. All 16 patients are still alive. Mean recurrence-free survival after primary tumour operation was 49.8 versus 24.6 months after liver surgery. Complications of cherry picking included two postoperative biliary leakages and three small hepatic abscesses (conservative/interventional approach 25 % (n = 4), surgical approach 6.25 % (n = 1). There was no postoperative mortality. Initial hormonal symptoms (5/16 patients) completely disappeared postoperatively in 2 patients and were significantly decreased in 3 patients.

CONCLUSIONS

The tissue-preserving surgical technique "cherry picking" has developed due to improved imaging techniques and increased knowledge in liver anatomy, which has helped to make this approach safer and easier. Highly selected patients with multiple bilobular liver metastases of GEP-NET can benefit from this special surgical approach, also applicable for recurrent metastases.

摘要

引言

胃肠胰神经内分泌肿瘤(GEP-NETs)的肝转移是一个已知的主要预后因素,对患者的生存有很大影响。迄今为止,有多种治疗选择,而手术仍然是唯一的治愈性选择。由于残余肝体积不足,往往无法进行大范围肝切除,一种特殊的手术技术“摘樱桃术”(多次非解剖性肝切除)可作为一种保留组织的手术方法。

方法

在91例患有各种GEP-NETs的患者中,有16例被确定为同时性或异时性多灶性、双叶肝转移(>10个)。所有患者均接受“摘樱桃术”治疗。对患者记录进行回顾性审查,并分析临床数据和病理结果。

结果

原发肿瘤切除后的平均生存期为82.8个月,而肝手术后为41.2个月。所有16例患者均存活。原发肿瘤手术后的平均无复发生存期为49.8个月,而肝手术后为24.6个月。“摘樱桃术”的并发症包括2例术后胆漏和3例小肝脓肿(保守/介入治疗占25%(n = 4),手术治疗占6.25%(n = 1))。无术后死亡病例。初始激素症状(5/16例患者)在术后2例患者中完全消失,3例患者中显著减轻。

结论

由于成像技术的改进和肝脏解剖学知识的增加,保留组织的手术技术“摘樱桃术”得到了发展,这有助于使该方法更安全、更容易。高度选择的GEP-NET双叶肝多发转移患者可从这种特殊的手术方法中获益,该方法也适用于复发性转移。

相似文献

1
"Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.“摘樱桃”法,一种多部位非解剖性肝切除技术,是神经内分泌肿瘤患者弥漫性肝转移的一种有前景的选择。
World J Surg. 2014 Feb;38(2):392-401. doi: 10.1007/s00268-013-2267-3.
2
Hepatic surgery for metastases from neuroendocrine tumors.神经内分泌肿瘤肝转移的肝手术治疗
Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. doi: 10.1016/s1055-3207(02)00076-5.
3
Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.内分泌转移瘤肝切除术后的临床及影像学随访:一项为期15年的单中心经验
Endocr Relat Cancer. 2009 Sep;16(3):977-90. doi: 10.1677/ERC-08-0247. Epub 2009 May 26.
4
Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.全胰切除术和肝移植治疗胰腺转移性神经内分泌肿瘤——单中心10例患者的经验
Langenbecks Arch Surg. 1999 Aug;384(4):370-7. doi: 10.1007/s004230050216.
5
Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy?神经内分泌转移瘤的肝脏定向手术:最佳策略是什么?
Surgery. 2016 Jan;159(1):320-33. doi: 10.1016/j.surg.2015.05.040. Epub 2015 Oct 9.
6
Hepatic neuroendocrine metastases: does intervention alter outcomes?肝神经内分泌转移瘤:干预措施会改变预后吗?
J Am Coll Surg. 2000 Apr;190(4):432-45. doi: 10.1016/s1072-7515(00)00222-2.
7
Synchronous resection of primary and liver metastases for neuroendocrine tumors.同步切除原发灶和肝脏转移灶治疗神经内分泌肿瘤。
Ann Surg Oncol. 2012 Dec;19(13):4270-7. doi: 10.1245/s10434-012-2462-8. Epub 2012 Jul 3.
8
Two-stage hepatectomy (R0) with portal vein ligation--towards curing patients with extended bilobular colorectal liver metastases.门静脉结扎的两阶段肝切除术(R0)——旨在治愈广泛性双叶结直肠癌肝转移患者。
Int J Colorectal Dis. 2009 Apr;24(4):409-18. doi: 10.1007/s00384-008-0620-z. Epub 2008 Dec 16.
9
Hepatic Resection for Metastatic Neuroendocrine Cancer in Patients with Bone Metastases.对骨转移患者的转移性神经内分泌癌进行肝切除术。
Ann Surg Oncol. 2016 Oct;23(11):3693-3698. doi: 10.1245/s10434-016-5274-4. Epub 2016 May 17.
10
Hepatic parenchymal preserving technique in the management of diffuse bilateral neuroendocrine tumour liver metastases: a feasible approach.保留肝实质技术在弥漫性双侧神经内分泌肿瘤肝转移瘤治疗中的应用:一种可行的方法。
Can J Surg. 2014 Apr;57(2):E2-8. doi: 10.1503/cjs.014112.

引用本文的文献

1
Parenchyma-sparing strategy and oncological prognosis in patients with colorectal cancer liver metastases.结直肠癌肝转移患者的实质保留策略与肿瘤学预后
World J Surg Oncol. 2022 Apr 17;20(1):122. doi: 10.1186/s12957-022-02579-1.
2
Technique of vessel-skeletonized parenchyma-sparing hepatectomy for the oncological treatment of bilobar colorectal liver metastases.血管骨架化肝段及肝叶切除术在结直肠肝转移癌中的应用技术。
Langenbecks Arch Surg. 2022 Mar;407(2):685-697. doi: 10.1007/s00423-021-02373-9. Epub 2021 Nov 27.
3
Systematic extended posterior right sectionectomy with simultaneous resection of the dorsal part of segment 1 and middle hepatic vein detachment.

本文引用的文献

1
Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database.肝移植治疗神经内分泌肿瘤肝转移:美国器官共享联合网络数据库分析
Arch Surg. 2011 Aug;146(8):953-8. doi: 10.1001/archsurg.2011.186.
2
Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis.手术与动脉内治疗神经内分泌肝脏转移:一项多中心国际分析。
Ann Surg Oncol. 2011 Dec;18(13):3657-65. doi: 10.1245/s10434-011-1832-y. Epub 2011 Jun 17.
3
New therapeutic options for metastatic malignant insulinomas.
系统性扩大右后叶切除术,同时切除第1段背侧部分并离断肝中静脉。
Clin Case Rep. 2021 Sep 12;9(9):e04803. doi: 10.1002/ccr3.4803. eCollection 2021 Sep.
4
Colorectal cancer liver metastases within the central and peripheral segments: Parenchymal sparing surgery adaptation.中央和外周肝段内的结直肠癌肝转移:保留实质的手术适应症。
Ann Med Surg (Lond). 2020 Aug 14;58:8-13. doi: 10.1016/j.amsu.2020.07.052. eCollection 2020 Oct.
5
Resection of Liver Metastases: A Treatment Provides a Long-Term Survival Benefit for Patients with Advanced Pancreatic Neuroendocrine Tumors: .肝转移灶切除术:一种为晚期胰腺神经内分泌肿瘤患者带来长期生存获益的治疗方法
J Oncol. 2018 Nov 14;2018:6273947. doi: 10.1155/2018/6273947. eCollection 2018.
6
Retrospective analysis of interventional treatment of hepatic metastasis from gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤肝转移介入治疗的回顾性分析
Chin J Cancer Res. 2017 Dec;29(6):581-586. doi: 10.21147/j.issn.1000-9604.2017.06.13.
7
Superselective intra-arterial hepatic injection of indocyanine green (ICG) for fluorescence image-guided segmental positive staining: experimental proof of the concept.用于荧光图像引导节段性阳性染色的超选择性肝动脉内注射吲哚菁绿(ICG):概念的实验证明
Surg Endosc. 2017 Mar;31(3):1451-1460. doi: 10.1007/s00464-016-5136-y. Epub 2016 Aug 5.
8
Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors.积极的局部区域治疗可改善3级胃肠胰神经内分泌肿瘤肝转移的预后。
Medicine (Baltimore). 2015 Aug;94(34):e1429. doi: 10.1097/MD.0000000000001429.
转移性恶性胰岛素瘤的新治疗选择。
Clin Endocrinol (Oxf). 2011 Sep;75(3):277-84. doi: 10.1111/j.1365-2265.2011.04145.x.
4
[Resection of metastases in neuroendocrine tumors: pro].[神经内分泌肿瘤转移灶的切除:支持观点]
Dtsch Med Wochenschr. 2011 Apr;136(17):896. doi: 10.1055/s-0031-1275824. Epub 2011 Apr 26.
5
[Pathology of neuroendocrine neoplasms].[神经内分泌肿瘤的病理学]
Chirurg. 2011 Jul;82(7):567-73. doi: 10.1007/s00104-011-2067-y.
6
A review of systemic and liver-directed therapies for metastatic neuroendocrine tumors of the gastroenteropancreatic tract.胃肠道胰神经内分泌肿瘤系统及肝脏导向治疗的研究进展。
Cancer Control. 2011 Apr;18(2):127-37. doi: 10.1177/107327481101800207.
7
Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin.空肠/回肠和胰腺来源的晚期神经内分泌癌的治疗策略。
Gut. 2011 Jul;60(7):1009-21. doi: 10.1136/gut.2009.204453. Epub 2011 Mar 4.
8
The ENETS guidelines: the new TNM classification system.欧洲神经内分泌肿瘤学会(ENETS)指南:新的TNM分类系统
Tumori. 2010 Sep-Oct;96(5):806-9. doi: 10.1177/030089161009600532.
9
Long-term survival after surgical management of neuroendocrine hepatic metastases.神经内分泌肝脏转移瘤的手术治疗后长期生存。
HPB (Oxford). 2010 Aug;12(6):427-33. doi: 10.1111/j.1477-2574.2010.00198.x.
10
Multimodal management of neuroendocrine liver metastases.神经内分泌肝脏转移的多模态管理。
HPB (Oxford). 2010 Aug;12(6):361-79. doi: 10.1111/j.1477-2574.2010.00175.x.